Form 4 Tracker
Natera, Inc.
NTRA

118 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 12, 2026Mar 12 8:29 PMMATTHEW RABINOWITZ
Proposed Sale
200,000$196.61$39.3M

View →

Mar 10, 2026Mar 12 1:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
785$204.13$160.2K63,354(D)

View →

Mar 10, 2026Mar 12 1:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
5,623$204.13$1.1M156,607(D)

View →

Mar 10, 2026Mar 12 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
1,745$204.13$356.2K233,285(D)

View →

Mar 10, 2026Mar 12 1:05 AMJonathan SheenaDirector, Other
Sale
127$204.13$25.9K262,325(D)

View →

Mar 10, 2026Mar 12 1:05 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
707$204.13$144.3K189,199(D)

View →

Mar 10, 2026Mar 11 10:05 PMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
915$204.13$186.8K150,882(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Sale
8,398$196.08$1.6M233,285(D)

View →

Mar 6, 2026Mar 6 9:29 PMDANIEL RABINOWITZ
Proposed Sale
16,798$197.14$3.3M

View →

Mar 2, 2026Mar 4 2:05 AMJonathan SheenaDirector, Other
Sale
3,070$200.23$614.7K262,194(D)

View →

Mar 2, 2026Mar 4 2:05 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
3,950$200.02$790.1K156,607(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
3,000$199.85$599.5K150,023(D)

View →

Mar 2, 2026Mar 2 9:12 PMSTEVEN L CHAPMAN
Proposed Sale
3,950$200.02$790.1K

View →

Mar 2, 2026Mar 2 9:11 PMSOLOMON MOSHKEVICH
Proposed Sale
3,000$199.85$599.5K

View →

Feb 3, 2026Feb 5 2:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
1,639$230.77$378.2K137,847(D)

View →

Feb 2, 2026Feb 5 2:35 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Sale
3,000$231.44$694.3K139,486(D)

View →

Feb 3, 2026Feb 5 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
4,725$230.77$1.1M123,156(D)

View →

Feb 2, 2026Feb 5 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Sale
85,299$230.72$19.7M127,881(D)

View →

Feb 3, 2026Feb 5 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Sale
6,939$227.83$1.6M52,120(D)

View →

Feb 3, 2026Feb 5 2:05 AMJohn FeskoPRESIDENT, CHIEF BUS. OFFICER
Sale
3,594$231.02$830.3K178,081(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,3860(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,5220(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
1910(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
8560(D)

View →